← Back to Search

Corticosteroid

PRP vs Corticosteroids for Basal Joint Osteoarthritis

N/A
Recruiting
Research Sponsored by Kettering Health Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Stage 1-3 osteoarthritis of the basal joint
Be older than 18 years old
Must not have
Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton
Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial is testing whether or not a type of blood injection called PRP is more effective than a corticosteroid for treating arthritis in the basal joint.

Who is the study for?
This trial is for people with early to moderate osteoarthritis in the basal joint of the thumb. It's not suitable for those with fibromyalgia, inflammatory diseases, bone tumors, certain wrist conditions like DeQuervain's tenosynovitis recently treated or advanced arthritis as per Eaton stage 4. Pregnant or terminally ill patients and those who've had a corticosteroid injection in the past year at the affected site are also excluded.Check my eligibility
What is being tested?
The study tests three treatments: platelet concentrate (PRP), corticosteroid injections, and placebo (normal saline) injected into the joint. Participants won't know which treatment they're getting but will be randomly assigned to one of these options to compare effectiveness.See study design
What are the potential side effects?
Possible side effects include pain at injection site, infection risk increase due to needle insertion, allergic reactions especially from corticosteroids which may also raise blood sugar levels temporarily.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My arthritis in the thumb joint is at an early to moderate stage.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My thumb joint arthritis is severe (Stage 4).
Select...
I have Pressier disease, Kienbock's, or avascular necrosis of the scaphoid.
Select...
I have fibromyalgia or an inflammatory rheumatic disease.
Select...
I've had a corticosteroid injection in my thumb joint within the last year.
Select...
I have arthritis in specific wrist joints.
Select...
I have or was treated for wrist tendon issues in the last 3 months.
Select...
I have had a bone tumor in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Disabilities arm shoulder and hand score
Secondary outcome measures
Pinch Strength
Other outcome measures
Visual Analog Score

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: PRPExperimental Treatment1 Intervention
Intra-articular injection of platelet rich plasma.
Group II: CorticosteroidActive Control1 Intervention
Intra-articular injection of kenalog.
Group III: Normal SalinePlacebo Group1 Intervention
Intra-articular injection of normal saline

Find a Location

Who is running the clinical trial?

Kettering Health NetworkLead Sponsor
19 Previous Clinical Trials
1,707 Total Patients Enrolled

Media Library

Corticosteroid injection (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT03196310 — N/A
Osteoarthritis Research Study Groups: Normal Saline, Corticosteroid, PRP
Osteoarthritis Clinical Trial 2023: Corticosteroid injection Highlights & Side Effects. Trial Name: NCT03196310 — N/A
Corticosteroid injection (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03196310 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03196310 — N/A
~15 spots leftby Mar 2025